Research identified key protein not previously observed in prostate cancer published in peer-reviewed Journal of Cancer
Paradigm Pharmaceuticals (ASX: PAR) conducting a clinical trial on the use of PPS to treat bone marrow oedema – Channel 7 News story
You must be logged in to post a comment.